What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza?

Expert Review of Respiratory Medicine

Volumn 9, Issue 1, 2015, Pages 1-3

  Alcorn, John F ^a,b   Sarkar, Saumendra N ^b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Influenza; interferon; OASL; RIG I

Indexed keywords

INTERFERON; OLIGOADENYLATE SYNTHETASE LIKE PROTEIN; SYNTHETASE; UNCLASSIFIED DRUG; VIRUS RNA; 2',5' OLIGOADENYLATE SYNTHETASE; ANTIVIRUS AGENT; OASL PROTEIN, HUMAN;

DRUG MECHANISM; HUMAN; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; MORTALITY; NONHUMAN; PANDEMIC; REVIEW; SEASONAL INFLUENZA; VIRUS VIRULENCE; ANIMAL; DRUG EFFECTS; GENE THERAPY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PATHOGENICITY; PROCEDURES; VIROLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIVIRAL AGENTS; GENETIC THERAPY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; RNA, VIRAL;

EID: 84920992459     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2015.994608     Document Type: Review

References (20)

1. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008; 8(12):911-22
2. Fernandez-Sesma A. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets 2007;7(4):336-43
3. Zhu J, Zhang Y, Ghosh A, et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity 2014;40(6): 936-48
4. Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 2010; 10(7):514-26
5. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008;8(7):559-68
6. Schoggins JW, Macduff DA, Imanaka N, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2014;505(7485):691-5
7. Mibayashi M, Martinez-Sobrido L, Loo YM, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007;81(2):514-24
8. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006;314(5801):997-1001
9. Gack MU, Albrecht RA, Urano T, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009;5(5):439-49
10. Talon J, Horvath CM, Polley R, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000;74(17):7989-96
11. Hale BG, Jackson D, Chen YH, et al. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 2006;103(38):14194-9
12. Stasakova J, Ferko B, Kittel C, et al. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and J Gen Virol 2005;86(Pt 1):185-95
13. Kristiansen H, Gad HH, Eskildsen-Larsen S, et al. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 2011;31(1):41-7
14. Sun L, Wu J, Du F, et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339(6121):786-91
15. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011;472(7344):481-5
16. Lee MS, Kim B, Oh GT, et al. OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol 2013;14(4):346-55
17. O'Neill LA, Bowie AG. The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 2011;147(2): 259-61
18. Peisley A, Wu B, Yao H, et al. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 2013;51(5):573-83
19. Gack MU, Shin YC, Joo CH, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007;446(7138):916-20
20. Zeng W, Sun L, Jiang X, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010; 141(2):315-30